Therapeutic Strategies in Pulmonary Hypertension of the Newborn: Where Are We Now?

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|27|4640-4653

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.27, 2012-09, pp. : 4640-4653

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intermediate care – where are we now?

By Harari Danielle  

Clinical Medicine, Vol. 2, Iss. 5, 2002-09 ,pp. : 477-479

Royal College Of Physicians

Access to resources Recommend Favorite

Discovery and ADMET: Where Are We Now

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 4, 2011-02 ,pp. : 467-481

Bentham Science Publishers

Access to resources Recommend Favorite

Persistent Pulmonary Hypertension of the Newborn: Pathogenesis, Etiology, and Management

By Ostrea Enrique M.   Villanueva-Uy Esterlita T.   Natarajan Girija   Uy Herbert G.  

Pediatric Drugs, Vol. 8, Iss. 3, 2006-01 ,pp. : 179-188

Adis International

Access to resources Recommend Favorite

Persistent Pulmonary Hypertension of the Newborn: Therapeutical Approach

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 14, 2008-12 ,pp. : 1507-1513

Bentham Science Publishers

Access to resources Recommend Favorite

The Second Window of Preconditioning (SWOP) Where Are We Now?

By Hausenloy Derek   Yellon Derek  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 235-254

Springer Publishing Company

Access to resources Recommend Favorite